US Patent Issued to DUKE UNIVERSITY on Jan. 27 for "Methods of treating ATPase-mediated diseases with a nucleic acid encoding ATP1A3 and a neuron-specific promoter" (North Carolina Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,397, issued on Jan. 27, was assigned to DUKE UNIVERSITY (Durham, N.C.).

"Methods of treating ATPase-mediated diseases with a nucleic acid encoding ATP1A3 and a neuron-specific promoter" was invented by Mohamad Mikati (Durham, N.C.), Arsen Hunanyan (Durham, N.C.), Boris Kantor (Durham, N.C.), Aravind Asokan (Durham, N.C.), Ram Puranam (Durham, N.C.) and Dwight Koeberl (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides nucleic acid expression cassettes, vectors, compositions and methods for the treatment of ATPase-mediated diseases in a subject."

The patent was filed on June 23, 2023, under Application No. 18...